Funding for this research was provided by:
Beijing Science & Technology Development of Traditional Chinese Medicine (BJZYQN-2025-11)
China Postdoctoral Science Foundation (2025M781685)
Talent development plan for the future in Medical-Engineering Integration by BRA-CDCHE and ZTA (MBRC0012025013)
State Key Laboratory of Innovative Immunotherapy
Beijing Municipal Natural Science Foundation (L234017)
Beijing Nova Program (20240484655)
National Natural Science Foundation of China (82230030)
Peking University Medicine plus X Pilot Program-Key Technologies R&D Project (2024YXXLHGG004)
Article History
Received: 19 April 2026
Accepted: 22 June 2026
First Online: 29 June 2026
Declarations
:
: Not applicable.
: The authors declare no competing interests.